We work for a healthier world where the burden of disease is lightened through accessible, affordable, tailored therapies.
We discover and deliver selectively designed drug innovations that enhance the treatment experience. It all starts with the patient.
Moving beyond traditional therapies, we aim to improve adherence journeys for patients whose needs have been overlooked.
Latest News
Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding
Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements
Scienture Holdings Announces Cancelation of ELOC
SCIENTURE Announces Executive Leadership Transition
SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL.
SCIENTURE announces manufacturing and supply chain readiness for Arbli™, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.
See all
We invest in Delivering Better™
We are focused on identification and thoughtful selection of key access, commercialization, and support partners.
